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•  M.	  tuberculosis	   is	  the	  major	  ae;ological	  agent	  causing	  
human	  tuberculosis	  (TB)	  
•  2011	  –	  8.7	  million	  new	  and	  relapsed	  TB	  infec;ons	  	  
•  13%	  involved	  co-­‐infec;on	  with	  HIV	  	  
•  Ranks	   second	   only	   to	   HIV	   among	   infec;ous	   killers	  
worldwide	  
•  TransmiMed	   by	   air	   –	   ac;ve	   bacilli	   in	   air	   droplets	  
expelled	  by	  people	  affected	  with	  pulmonary	  TB	  
•  Problems	   in	   comba;ng	   TB:	   limita;ons	   in	   current	   TB	  
therapies,	  persistence,	  mul;-­‐drug	  resistance,	  etc..	  
TB	  and	  Mycobacterium	  tuberculosis	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•  At	  least	  28	  F420-­‐
dependent	  enzymes	  
iden;fied	  in	  M.	  
tuberculosis1	  
•  Molecular	  structure	  
very	  similar	  to	  FMN	  
Our	  research	  focuses	  on	  	  
coenzyme	  F420,	  a	  flavin	  cofactor	  
1Selengut,	  J.	  D.,	  &	  Haj,	  D.	  H.	  (2010)	  Journal	  of	  Bacteriology,	  192(21),	  5788-­‐5798	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  FbiA        (phospholactate	  







	  	  	  FbiB 	  	  	  	  	  	  	  	  (glutamyl	  ligase)	  	  	  
(rv3262)	  
• 	  	  In	  mycobacterium	  species,	  the	  predominant	  
structures	  contain	  F420-­‐5	  and	  F420-­‐6	  glutamate	  
groups.	  
• 	  Polyglutamylated	  F420	  is	  a	  conserved	  feature	  
observed	  in	  reac;ons	  by	  F420-­‐dependent	  
enzymes	  
•  BLASTp:	  Comprises	  2	  domains	  
–  N-­‐terminal	  domain:	  	  
–  annotated	  as	  a	  gamma-­‐glutamyl	  ligase	  (Pfam	  PF01996)	  
–  37%	  sequence	  iden;ty	  with	  an	  archaeal	  γ-­‐glutamyl	  ligase	  (PDB	  
ID	  2G9I)	  
–  C-­‐terminal	  domain:	  
–  sequence-­‐similarity	  to	  FMN-­‐dependent	  nitroreductase	  family	  
(Pfam	  PF0081)	  
–  Has	  been	  hypothesized	  to	  facilitate	  elonga;on	  of	  polyglutamate	  
tail	  of	  F420	  in	  mycobacterial	  species	  (NCBI	  CDD	  TIGR03553)	  
•  It	  is	  postulated	  that	  N-­‐terminal	  domain	  would	  add	  up	  to	  2	  
glutamate	  residues	  to	  the	  coenzyme	  as	  seen	  in	  
methanogens,	  and	  the	  C-­‐terminal	  domain	  would	  add	  more	  
glutamate	  residues	  to	  the	  coenzyme	  
FbiB	  
hMp://blast.ncbi.nlm.nih.gov/BLAST.cgi,	  hMp://www.uniprot.org	  	  
•  Gateway	  cloning	  (6XHis-­‐tagged,	  GST-­‐tagged)	  
•  Readily	  expressed	  and	  purified	  as	  full	  length	  and	  
individual	  domain	  constructs	  
•  In	  both	  E.	  coli	  and	  M.	  smegma;s	  vectors	  
•  However,	  only	  its	  C-­‐terminal	  domain	  was	  
successfully	  crystallized	  
•  The	  3-­‐dimensional	  structure	  of	  FbiB	  C-­‐terminal	  
domain	  was	  determined	  to	  1.75Å	  resolu;on	  
•  Phased	  by	  mul;wavelength	  anomalous	  
dispersion	  (MAD)	  methods	  using	  bromide-­‐soaked	  
crystals	  
FbiB	  cloning,	  expression,	  purifica;on,	  
and	  crystallisa;on	  
Top:	  Apo-­‐crystals	  of	  
FbiB	  C-­‐terminal	  domain	  
(refined	  to	  1.75Å)	  
Top:	  FMN-­‐soaked	  FbiB	  C-­‐
terminal	  domain	  crystals	  
(refined	  to	  1.9Å)	  
	  
	  
BoMom:	  F420-­‐0	  soaked	  FbiB	  C-­‐
terminal	  domain	  (refined	  to	  
1.9Å)	  
	  
Diffrac;on	  image	  of	  	  
Lej:	  apo-­‐FbiB	  C-­‐terminal	  
domain	  crystals	  	  
Right:	  FMN-­‐soaked	  FbiB	  C-­‐
domain	  crystals	  
C-­‐terminal	  domain	  X-­‐ray	  data	  and	  
Structure	  determina;on	  
Crystal	  data	  for	  different	  crystal	  	  
forms	  of	  FbiB	  C-­‐terminal	  domain	  
•  Contain	  two	  dimers	  in	  the	  asymmetric	  unit	  
•  Top	  and	  side	  view	  of	  the	  FbiB	  
C-­‐domain	  dimer	  
–  The	  an;parallel	  beta	  strands	  
at	  the	  protein	  core	  are	  flanked	  
by	  helices.	  
–  monomer	  A	  is	  rainbow-­‐
coloured	  from	  its	  N-­‐terminus	  
(blue)	  to	  C-­‐terminus	  (red)	  
whereas	  monomer	  B	  is	  in	  
grey.	  	  
–  Displays	  a	  fold	  that	  is	  typical	  
of	  FMN-­‐dependent	  
nitroreductases	  family	  
Structure	  of	  FbiB	  C-­‐
domain	  dimer	  
Refinement	  sta;s;cs:	  Rfactor/Rfree	  (%)	  =	  22.3/25.7,	  rmsd	  =	  0.010Å,	  97.5%	  	  
residues	  in	  most	  favoured	  regions,	  one	  ramachandran	  outlier	  
FMN	  
F420-­‐0	  
Electron	  density	  map	  around	  FMN	  and	  F420-­‐0	  
molecule	  (contoured	  at	  1.5	  sigma)	  
Overlay	  of	  FMN-­‐bound	  and	  F420	  bound	  structures:	  
Lej:	  The	  protein	  dimer	  is	  represented	  as	  a	  ribbon	  diagram	  and	  ligands	  as	  s;ck	  
models	  	  
Right:	  The	  protein	  dimer	  as	  a	  surface	  representa;on	  with	  ligands	  as	  spheres	  on	  the	  
right	  	  
Different	  binding	  sites	  for	  FMN	  	  
and	  F420-­‐0	  molecule	  
•  Full	  length	  FbiB	  and	  its	  individual	  domain	  constructs	  
readily	  expressed	  and	  purified	  in	  both	  E.	  coli	  and	  M.	  
smegma;s	  
•  Only	  C-­‐terminal	  domain	  of	  FbiB	  has	  been	  successfully	  
crystallised	  
•  The	  structure	  of	  apo-­‐FbiB	  C-­‐terminal	  domain,	  as	  well	  
as	  FMN-­‐bound	  and	  F420-­‐0-­‐bound	  FbiB	  C-­‐terminal	  
domain	  has	  been	  solved	  
•  Closer	  inspec;on	  revealed	  different	  conserved	  binding	  
sites	  for	  FMN	  and	  F420-­‐0	  ligand	  
•  As	  FMN	  is	  not	  a	  natural	  ligand	  for	  FbiB	  enzyme,	  its	  role	  
will	  need	  to	  be	  further	  inves;gated	  
Summary	  
Thank	  you	  for	  your	  aMen;on	  
•  can	   remain	   dormant	   for	   a	   long	   ;me	   before	  
becoming	   infec;ous	   when	   the	   immune	   system	  
of	  the	  host	  is	  compromised	  
•  a	   non-­‐sporula;ng	   bacterium,	   yet	   can	   remain	  
dormant	  within	  the	  human	  host	  for	  years	  
•  can	   survive	   in	   hypoxic	   (oxygen-­‐depleted)	   and	  
nutrient-­‐depleted	  media	  
TB	  and	  M.	  tuberculosis	  
Russell,	  D.	  G.	  (2007)	  Nature	  Reviews.	  Microbiology,	  5(1),	  39-­‐47.	  
HeM,	  E.	  G.,	  &	  Rubin,	  E.	  J.	  (2008).	  Microbiology	  and	  molecular	  biology	  reviews:	  MMBR,	  72
(1),	  126-­‐156.	  
•  it	   plays	   important	   roles	   in	   par;cular	   condi;on	  
such	   as	   hypoxia	   –	   may	   be	   relevant	   to	  
mycobacterial	  persistence	  
•  Low-­‐cross	   ac;va;on	   by	   mammalian	   enzymes	   –
make	  F420-­‐related	  proteins	  promising	  drug	  targets	  
•  Structural	   informa;on	  on	  enzymes	   from	  the	  F420	  
biosynthesis	   pathway	  might	   provide	   informa;on	  
on	   how	   this	   coenzyme	   is	   regulated	   in	  
mycobacteria,	  and	  how	  they	  might	  be	  developed	  
as	  therapeu;c	  targets	  
Relevance	  of	  studying	  coenzyme	  F420	  
in	  mycobacteria	  
•  Solved	  using	  mul;-­‐wavelength	  anomalous	  
dispersion	  (MAD)	  methods	  for	  phase	  
determina;on	  
•  	  Halide	  (bromide)	  soaked	  FbiB	  C-­‐terminal	  
domain	  crystals	  –	  display	  significant	  
anomalous	  signal	  that	  can	  be	  used	  as	  a	  
reference	  to	  locate	  the	  posi;ons	  of	  these	  
atoms	  
Solu;on	  of	  apo-­‐FbiB	  C-­‐terminal	  
domain	  structure	  
